Empowering Innovation withState-of-the-Art Infrastructure
CRAMSN Research Park offers cutting-edge infrastructure and comprehensive capabilities to meet client needs from discovery through commercialization.
1
State-of-the-art R&D Centers
18
API Manufacturing Units
7
Fully-Integrated FDF Facilities
1
Fully-Integrated FDF Facility in New New Jersey, USA.
Through in-depth analyses and expert insights, CRAMSYNTH Pulse highlights groundbreaking advancements and practical applications within the field, reflecting our commitment to excellence and innovation in scientific research and development.
End-to-End Solutions
CRAMSN Research Park offers comprehensive one-stop-shop CRO, CDMO, and CMO services with scalable infrastructure supporting everything from grams to tonnes production.
Research & Development
40 advanced chemistry labs with specialized capabilities for diverse pharmaceutical development needs.
- Route scouting and feasibility studies
- QbD-based optimization
- Process development and scale-up
- Technology transfer support
ManufacturingExcellence
cGMP-compliant manufacturing facilities with continuous process- ing capabilities.
- Clinical trial manufacturing
- Commercial scale production
- Regulatory-compliant operations
- Flexible campaign-based production
Analytical Services
45,000 sq ft dedicated analytical facility with comprehensive testing capabilities.
- Method development and validation
- Genotoxic impurity assessments
- Nitrosamine impurity testing
- Stability studies and analysis
Specialized Laboratories
Our R&D center hosts dedicated labs tailored for diverse specialties, including:
- High-potency active pharmaceutical ingredients (HPAPIs)
- Prostaglandins, labeled compounds, and iron complexes
- Flow chemistry, peptides, oligonucleotides
- Particle size engineering
Advanced Synthetic Capabilities
Specialized engineering labs focusing on process safety studies and process intensification to enhance operational efficiency.
40
Synthetic Labs
~350
Fume Hoods
Scale-Up Facilities
10 L - 100 L
Reactor capacities under CGMP standards
PHASE I, II & III
CLINICAL TRIALS
Clean room facilities ensuring stringent compliance with clinical development needs.
CRAMSN’s manufacturing infrastructure is built to support production at every scale, from grams to tons, while upholding the highest standards of quality and compliance. Our advanced drug substance and drug product facilities are equipped to fulfill a diverse range of client requirements.
Drug Substance Manufacturing
Our API manufacturing capabilities include a robust setup for producing a diverse array of drug substance
ManufacturingScale
17
Manufacturing Facilities
2,400 +
Reactors
10,000 KL
Combined Reaction Volume
Cryogenic Reactor
12 KL
Operating Range: -90°C to 140°C Specialized for temperature-sen-sitive reactions
2 HPAPI Facilities
< 0.1 Mg/M3
Ultra-low exposure containment OEB 5 compliance capability
Hydrogenation Facility
6 KL
Pressure Range: 5 - 10Kg/cm2 Specialized hydrogenation capabilities
Spray Dryer
10 KG/BATCH
Liquid formulation capabilities for pediatric and specialized dosing
Particle Size Reduction
< 10 MICRON
GMCA & Non-GMCA facility in class 100,000 area Precision particle engineering
Reactor Range
20 L - 20 KL
Capacities for tailored production scalability.
Drug Product Manufacturing
CRAMSN’s extensive FDF manufacturing capabilities allow for high-volume production across a wide variety of drug forms.
FDF Production Capacities
Tablets
~12 Bn
High-speed tablet manufacturing with advanced compression technology
Capsules
~100 Mn
Hard and soft gelatin capsule manufacturing
Sachets
~100 Mn
Flexible sachet packaging for powder and granule formulations
Oral Suspensions
~7Mn
Liquid formulation capabilities for pediatric and specialized dosing
Parenterals (Lyo & Liquids)
~ 40 Mn
Lyophilized & liquid injectable formulations
Granules
~100 Tons
Large-scale capsule production forbulk requirements
Compliance & Quality Standards
Meeting the highest international regulatory standards for pharmaceutical manufacturing and development.
